世界の慢性尋常性乾癬治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Chronic Plaque Psoriasis Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1328 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、慢性尋常性乾癬治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（臨床、非臨床、非アクティブ）、用途別市場規模（病院、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・慢性尋常性乾癬治療の市場動向 ・企業の競争状況、市場シェア ・慢性尋常性乾癬治療の種類別市場規模（臨床、非臨床、非アクティブ） ・慢性尋常性乾癬治療の用途別市場規模（病院、外来手術センター、その他） ・慢性尋常性乾癬治療の北米市場規模2016-2027（アメリカ、カナダ） ・慢性尋常性乾癬治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・慢性尋常性乾癬治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・慢性尋常性乾癬治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・慢性尋常性乾癬治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbvie、Novartis International、Pfizer、Merck、Astelllas Pharma、GlaxoSmithKline） ・結論

Psoriasis is an autoimmune disease which is characterized by scaly patches of skin with inflammation and causes excessive production of new skin cells. Presently, there are no long term therapeutics available for the treatment of psoriasis. Chronic Plaque psoriasis is the one of the most common type of psoriasis. This disease condition is associated with several risk factors such as infection, psychological stress and others. Diagnosis of chronic plaque psoriasis is based on clinical appearance, is the case is severe then biopsy is recommended by the healthcare professionals in order to distinguish it from other conditions such as seborrheic dermatitis, ichen simplex chronicus and others.
Increasing uptake of biological drugs is one of the major factor propelling the growth of the global chronic plaque psoriasis therapeutics market. Advances in inflammation and immunology research, introduction of innovative drugs and increased focus on the usage of combination therapies are further accentuating the demand for chronic plaque psoriasis drugs.

Market Analysis and Insights: Global Chronic Plaque Psoriasis Therapeutics Market
The global Chronic Plaque Psoriasis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Plaque Psoriasis Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Plaque Psoriasis Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Plaque Psoriasis Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Plaque Psoriasis Therapeutics market.

Global Chronic Plaque Psoriasis Therapeutics Scope and Market Size
Chronic Plaque Psoriasis Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Plaque Psoriasis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Clinical
Non-Clinical
Inactive

Segment by Application
Hospitals
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbvie
Novartis International
Pfizer
Merck
Astelllas Pharma
GlaxoSmithKline

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Plaque Psoriasis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Clinical
1.2.3 Non-Clinical
1.2.4 Inactive
1.3 Market by Application
1.3.1 Global Chronic Plaque Psoriasis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Chronic Plaque Psoriasis Therapeutics Market Perspective (2016-2027)
2.2 Chronic Plaque Psoriasis Therapeutics Growth Trends by Regions
2.2.1 Chronic Plaque Psoriasis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chronic Plaque Psoriasis Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Chronic Plaque Psoriasis Therapeutics Industry Dynamic
2.3.1 Chronic Plaque Psoriasis Therapeutics Market Trends
2.3.2 Chronic Plaque Psoriasis Therapeutics Market Drivers
2.3.3 Chronic Plaque Psoriasis Therapeutics Market Challenges
2.3.4 Chronic Plaque Psoriasis Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Chronic Plaque Psoriasis Therapeutics Players by Revenue
3.1.1 Global Top Chronic Plaque Psoriasis Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Chronic Plaque Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Plaque Psoriasis Therapeutics Revenue
3.4 Global Chronic Plaque Psoriasis Therapeutics Market Concentration Ratio
3.4.1 Global Chronic Plaque Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Plaque Psoriasis Therapeutics Revenue in 2020
3.5 Chronic Plaque Psoriasis Therapeutics Key Players Head office and Area Served
3.6 Key Players Chronic Plaque Psoriasis Therapeutics Product Solution and Service
3.7 Date of Enter into Chronic Plaque Psoriasis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Plaque Psoriasis Therapeutics Breakdown Data by Type
4.1 Global Chronic Plaque Psoriasis Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Type (2022-2027)

5 Chronic Plaque Psoriasis Therapeutics Breakdown Data by Application
5.1 Global Chronic Plaque Psoriasis Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Chronic Plaque Psoriasis Therapeutics Market Size (2016-2027)
6.2 North America Chronic Plaque Psoriasis Therapeutics Market Size by Type
6.2.1 North America Chronic Plaque Psoriasis Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Chronic Plaque Psoriasis Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Chronic Plaque Psoriasis Therapeutics Market Size by Type (2016-2027)
6.3 North America Chronic Plaque Psoriasis Therapeutics Market Size by Application
6.3.1 North America Chronic Plaque Psoriasis Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Chronic Plaque Psoriasis Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Chronic Plaque Psoriasis Therapeutics Market Size by Application (2016-2027)
6.4 North America Chronic Plaque Psoriasis Therapeutics Market Size by Country
6.4.1 North America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Chronic Plaque Psoriasis Therapeutics Market Size (2016-2027)
7.2 Europe Chronic Plaque Psoriasis Therapeutics Market Size by Type
7.2.1 Europe Chronic Plaque Psoriasis Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Chronic Plaque Psoriasis Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Chronic Plaque Psoriasis Therapeutics Market Size by Type (2016-2027)
7.3 Europe Chronic Plaque Psoriasis Therapeutics Market Size by Application
7.3.1 Europe Chronic Plaque Psoriasis Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Chronic Plaque Psoriasis Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Chronic Plaque Psoriasis Therapeutics Market Size by Application (2016-2027)
7.4 Europe Chronic Plaque Psoriasis Therapeutics Market Size by Country
7.4.1 Europe Chronic Plaque Psoriasis Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Chronic Plaque Psoriasis Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Type
8.2.1 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Application
8.3.1 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Region
8.4.1 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Chronic Plaque Psoriasis Therapeutics Market Size (2016-2027)
9.2 Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Type
9.2.1 Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Application
9.3.1 Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Country
9.4.1 Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Type
10.2.1 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Application
10.3.1 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Country
10.4.1 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Details
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Chronic Plaque Psoriasis Therapeutics Introduction
11.1.4 Abbvie Revenue in Chronic Plaque Psoriasis Therapeutics Business (2016-2021)
11.1.5 Abbvie Recent Development
11.2 Novartis International
11.2.1 Novartis International Company Details
11.2.2 Novartis International Business Overview
11.2.3 Novartis International Chronic Plaque Psoriasis Therapeutics Introduction
11.2.4 Novartis International Revenue in Chronic Plaque Psoriasis Therapeutics Business (2016-2021)
11.2.5 Novartis International Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Chronic Plaque Psoriasis Therapeutics Introduction
11.3.4 Pfizer Revenue in Chronic Plaque Psoriasis Therapeutics Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Chronic Plaque Psoriasis Therapeutics Introduction
11.4.4 Merck Revenue in Chronic Plaque Psoriasis Therapeutics Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Astelllas Pharma
11.5.1 Astelllas Pharma Company Details
11.5.2 Astelllas Pharma Business Overview
11.5.3 Astelllas Pharma Chronic Plaque Psoriasis Therapeutics Introduction
11.5.4 Astelllas Pharma Revenue in Chronic Plaque Psoriasis Therapeutics Business (2016-2021)
11.5.5 Astelllas Pharma Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Chronic Plaque Psoriasis Therapeutics Introduction
11.6.4 GlaxoSmithKline Revenue in Chronic Plaque Psoriasis Therapeutics Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Chronic Plaque Psoriasis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Clinical
Table 3. Key Players of Non-Clinical
Table 4. Key Players of Inactive
Table 5. Global Chronic Plaque Psoriasis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Chronic Plaque Psoriasis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Chronic Plaque Psoriasis Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Chronic Plaque Psoriasis Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Chronic Plaque Psoriasis Therapeutics Market Share by Regions (2022-2027)
Table 11. Chronic Plaque Psoriasis Therapeutics Market Trends
Table 12. Chronic Plaque Psoriasis Therapeutics Market Drivers
Table 13. Chronic Plaque Psoriasis Therapeutics Market Challenges
Table 14. Chronic Plaque Psoriasis Therapeutics Market Restraints
Table 15. Global Chronic Plaque Psoriasis Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Chronic Plaque Psoriasis Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Chronic Plaque Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Plaque Psoriasis Therapeutics as of 2020)
Table 18. Ranking of Global Top Chronic Plaque Psoriasis Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Chronic Plaque Psoriasis Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Chronic Plaque Psoriasis Therapeutics Product Solution and Service
Table 22. Date of Enter into Chronic Plaque Psoriasis Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Chronic Plaque Psoriasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Chronic Plaque Psoriasis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Chronic Plaque Psoriasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Chronic Plaque Psoriasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Chronic Plaque Psoriasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Chronic Plaque Psoriasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Chronic Plaque Psoriasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Chronic Plaque Psoriasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Chronic Plaque Psoriasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Chronic Plaque Psoriasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Chronic Plaque Psoriasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Chronic Plaque Psoriasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbvie Company Details
Table 63. Abbvie Business Overview
Table 64. Abbvie Chronic Plaque Psoriasis Therapeutics Product
Table 65. Abbvie Revenue in Chronic Plaque Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Abbvie Recent Development
Table 67. Novartis International Company Details
Table 68. Novartis International Business Overview
Table 69. Novartis International Chronic Plaque Psoriasis Therapeutics Product
Table 70. Novartis International Revenue in Chronic Plaque Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Novartis International Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Chronic Plaque Psoriasis Therapeutics Product
Table 75. Pfizer Revenue in Chronic Plaque Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Merck Company Details
Table 78. Merck Business Overview
Table 79. Merck Chronic Plaque Psoriasis Therapeutics Product
Table 80. Merck Revenue in Chronic Plaque Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Merck Recent Development
Table 82. Astelllas Pharma Company Details
Table 83. Astelllas Pharma Business Overview
Table 84. Astelllas Pharma Chronic Plaque Psoriasis Therapeutics Product
Table 85. Astelllas Pharma Revenue in Chronic Plaque Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Astelllas Pharma Recent Development
Table 87. GlaxoSmithKline Company Details
Table 88. GlaxoSmithKline Business Overview
Table 89. GlaxoSmithKline Chronic Plaque Psoriasis Therapeutics Product
Table 90. GlaxoSmithKline Revenue in Chronic Plaque Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 91. GlaxoSmithKline Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Plaque Psoriasis Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Clinical Features
Figure 3. Non-Clinical Features
Figure 4. Inactive Features
Figure 5. Global Chronic Plaque Psoriasis Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Chronic Plaque Psoriasis Therapeutics Report Years Considered
Figure 10. Global Chronic Plaque Psoriasis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Chronic Plaque Psoriasis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Chronic Plaque Psoriasis Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Chronic Plaque Psoriasis Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Chronic Plaque Psoriasis Therapeutics Market Share by Players in 2020
Figure 15. Global Top Chronic Plaque Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Plaque Psoriasis Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Chronic Plaque Psoriasis Therapeutics Revenue in 2020
Figure 17. Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Chronic Plaque Psoriasis Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Chronic Plaque Psoriasis Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Chronic Plaque Psoriasis Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Chronic Plaque Psoriasis Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Chronic Plaque Psoriasis Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Chronic Plaque Psoriasis Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Share by Region (2016-2027)
Figure 39. China Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Chronic Plaque Psoriasis Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Chronic Plaque Psoriasis Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Chronic Plaque Psoriasis Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Abbvie Revenue Growth Rate in Chronic Plaque Psoriasis Therapeutics Business (2016-2021)
Figure 59. Novartis International Revenue Growth Rate in Chronic Plaque Psoriasis Therapeutics Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Chronic Plaque Psoriasis Therapeutics Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Chronic Plaque Psoriasis Therapeutics Business (2016-2021)
Figure 62. Astelllas Pharma Revenue Growth Rate in Chronic Plaque Psoriasis Therapeutics Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Chronic Plaque Psoriasis Therapeutics Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---